|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
CYP1A1 allele nomenclature
Changes
made since the last update (5 Allele frequencies: Solus et al., 2004 Links to the NCBI dbSNP homepage are available for functional SNPs when present in NCBI's database. Nucleotide variations in bold are the major SNPs/alterations responsible for the phenotype of the corresponding allele. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Note about CYP1A1 nomenclature
Unfortunately two different nomenclature systems were developed for the CYP1A1
alleles simultaneously. The authors of both nomenclature systems have agreed in
July 2000 that the nomenclature system given in this homepage should be the
recommended one. More information has been published in
Cancer
Epidemiology Biomarkers and Prevention.
Below is a table which will facilitate conversion between the two systems:
|
Recommended nomenclature on the homepage |
Nomenclature proposed by |
|
CYP1A1*1 |
CYP1A1*1 |
|
CYP1A1*2A |
CYP1A1*2 |
|
CYP1A1*2C |
CYP1A1*3 |
|
CYP1A1*3 |
CYP1A1*4 |
|
CYP1A1*4 |
CYP1A1*5 |
|
Home Page Inclusion criteria This page was updated
22-Dec-2009 by Sarah C Sim |